Jung Choi Global Blood Therapeutics, Inc. (GBT) insider trading activity

Jung Choi is Officer of Global Blood Therapeutics, Inc.. Currently has a direct ownership of 0 shares of GBT, which is worth approximately $0. The most recent transaction as insider was on Oct 05, 2022, when has been sold 226,672 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Jung Choi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 05 2022	SELL Sale (or disposition) back to the issuer	-	226,672 Reduced 100.0%	0 Common Stock
Sep 29 2022	SELL Bona fide gift	-	73,855 Reduced 24.58%	226,672 Common Stock
Sep 27 2022	BUY Exercise of conversion of derivative security	$1,838,557 $18.48 p/Share	99,489 Added 24.87%	300,527 Common Stock
Sep 01 2022	SELL Payment of exercise price or tax liability	$126,827 $68.15 p/Share	1,861 Reduced 0.92%	201,038 Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	-	4,971 Added 2.39%	202,899 Common Stock
Aug 01 2022	SELL Payment of exercise price or tax liability	$68,882 $32.4 p/Share	2,126 Reduced 1.06%	197,928 Common Stock
Aug 01 2022	BUY Exercise of conversion of derivative security	-	6,145 Added 2.98%	200,054 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$28,556 $29.87 p/Share	956 Reduced 0.5%	191,374 Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	-	2,763 Added 1.42%	192,330 Common Stock
Feb 01 2022	SELL Payment of exercise price or tax liability	$97,962 $29.33 p/Share	3,340 Reduced 1.73%	189,567 Common Stock
Feb 01 2022	BUY Exercise of conversion of derivative security	-	9,020 Added 4.47%	192,907 Common Stock
Sep 01 2021	SELL Payment of exercise price or tax liability	$40,895 $29.85 p/Share	1,370 Reduced 0.74%	183,887 Common Stock
Sep 01 2021	BUY Exercise of conversion of derivative security	-	2,762 Added 1.47%	185,257 Common Stock
Aug 31 2021	BUY Grant, award, or other acquisition	$3,122 $24.39 p/Share	128 Added 0.07%	182,495 Common Stock
Aug 01 2021	SELL Payment of exercise price or tax liability	$102,296 $27.33 p/Share	3,743 Reduced 2.01%	182,367 Common Stock
Aug 01 2021	BUY Exercise of conversion of derivative security	-	9,020 Added 4.62%	186,110 Common Stock
Feb 28 2021	BUY Grant, award, or other acquisition	$5,069 $36.21 p/Share	140 Added 0.08%	177,090 Common Stock
Feb 01 2021	SELL Payment of exercise price or tax liability	$229,931 $49.49 p/Share	4,646 Reduced 2.56%	176,950 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	-	13,083 Added 6.72%	181,596 Common Stock

Also insider at

ANNX

Annexon, Inc. Healthcare

Jung Choi

Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GBT shares.

Notify only if

Value

Insider Trading

Get notified when an Global Blood Therapeutics, Inc. insider buys or sells GBT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Global Blood Therapeutics, Inc.

Track Activities on GBT

Account